Page last updated: 2024-11-09

thiocarbohydrazide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID2724189
CHEMBL ID3181818
CHEBI ID9549
SCHEMBL ID220407
SCHEMBL ID21156695
MeSH IDM0057619

Synonyms (57)

Synonym
nsc 689
hydrazinecarbohydrazonothioic acid (van)
brn 0506657
ai3-52269
einecs 218-769-8
hsdb 5869
wln: zmyus&mz
hydrazinecarbohydrazonothioic acid
thiocarbonohydrazide
carbonothioic dihydrazide
thiocarbohydrazide
TCH ,
1,3-diamino-2-thiourea
thiocarbonic dihydrazide
nsc689
usaf ek-7372
thiocarbazide
carbohydrazide, thio-
2231-57-4
nsc-689
thiocarbohydrazide, 98%
STK141127
thiocarbohydrazide, purum p.a., for electron microscopy, >=99.0% (n)
T1136
AKOS001027231
1,3-diaminothiourea
NCGC00249036-01
unii-1iz2h82nwu
1iz2h82nwu ,
4-03-00-00388 (beilstein handbook reference)
cas-2231-57-4
NCGC00257056-01
dtxcid707461
tox21_303273
dtxsid7027461 ,
tox21_201365
NCGC00258917-01
FT-0634152
thiocarbonyldihydrazide
F3308-0307
1,3-diamino-2-thiourea [hsdb]
SCHEMBL220407
CHEBI:9549 ,
W-107486
CHEMBL3181818 ,
bdbm50064161
ch6n4s
Q7784653
SCHEMBL21156695
n,n'-diaminocarbamimidothioic acid
STR03786
mfcd00007616
AKOS037655878
CS-0149889
carbonothioicdihydrazide
EN300-16922
Z56823019
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
thiocarbonyl compoundAny compound containing the thiocarbonyl group, C=S.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (23)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency41.44623.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency51.84110.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency38.55340.000714.592883.7951AID1259368; AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency57.87340.000221.22318,912.5098AID743035; AID743042; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency62.48000.000657.913322,387.1992AID1259378
progesterone receptorHomo sapiens (human)Potency58.64780.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency73.71800.003041.611522,387.1992AID1159553
retinoid X nuclear receptor alphaHomo sapiens (human)Potency27.86610.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency55.76680.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency21.02230.375827.485161.6524AID743220; AID743239
estrogen nuclear receptor alphaHomo sapiens (human)Potency59.07450.000229.305416,493.5996AID743075
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency10.96220.001024.504861.6448AID743215
aryl hydrocarbon receptorHomo sapiens (human)Potency25.95470.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency50.38330.001723.839378.1014AID743083
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency40.001919.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency19.20480.057821.109761.2679AID1159526; AID1159528
Histone H2A.xCricetulus griseus (Chinese hamster)Potency46.84680.039147.5451146.8240AID1224845; AID1224896
Caspase-7Cricetulus griseus (Chinese hamster)Potency55.98200.006723.496068.5896AID1346980
caspase-3Cricetulus griseus (Chinese hamster)Potency55.98200.006723.496068.5896AID1346980
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency44.21830.000323.4451159.6830AID743065; AID743066
heat shock protein beta-1Homo sapiens (human)Potency1.94500.042027.378961.6448AID743210; AID743228
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency52.93800.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)178.30000.03403.987110.0000AID1192855
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1610307Antifungal activity against Aspergillus fumigatus CGMCC 3.7795 measured at 72 hrs by CLSI protocol based microbroth dilution method2019Bioorganic & medicinal chemistry letters, 12-01, Volume: 29, Issue:23
Design, synthesis and biological evaluation of novel semicarbazone-selenochroman-4-ones hybrids as potent antifungal agents.
AID1610305Antifungal activity against Candida zeylanoides CGMCC2.3739 measured at 24 hrs by CLSI protocol based microbroth dilution method2019Bioorganic & medicinal chemistry letters, 12-01, Volume: 29, Issue:23
Design, synthesis and biological evaluation of novel semicarbazone-selenochroman-4-ones hybrids as potent antifungal agents.
AID1610306Antifungal activity against Candida albicans SC5314 incubated for 24 hrs by CLSI protocol based microbroth dilution method2019Bioorganic & medicinal chemistry letters, 12-01, Volume: 29, Issue:23
Design, synthesis and biological evaluation of novel semicarbazone-selenochroman-4-ones hybrids as potent antifungal agents.
AID1192855Inhibition of mushroom tyrosinase using L-DOPA as substrate preincubated for 10 mins by spectrophotometry2015Bioorganic & medicinal chemistry, Mar-01, Volume: 23, Issue:5
Rational design, synthesis and structure-activity relationships of 4-alkoxy- and 4-acyloxy-phenylethylenethiosemicarbazone analogues as novel tyrosinase inhibitors.
AID1610303Antifungal activity against Candida albicans CPCC400616 measured at 24 hrs by CLSI protocol based microbroth dilution method2019Bioorganic & medicinal chemistry letters, 12-01, Volume: 29, Issue:23
Design, synthesis and biological evaluation of novel semicarbazone-selenochroman-4-ones hybrids as potent antifungal agents.
AID1610304Antifungal activity against Cryptococcus neoformans CGMCC2.3161 measured at 72 hrs by CLSI protocol based microbroth dilution method2019Bioorganic & medicinal chemistry letters, 12-01, Volume: 29, Issue:23
Design, synthesis and biological evaluation of novel semicarbazone-selenochroman-4-ones hybrids as potent antifungal agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (74)

TimeframeStudies, This Drug (%)All Drugs %
pre-199037 (50.00)18.7374
1990's19 (25.68)18.2507
2000's4 (5.41)29.6817
2010's11 (14.86)24.3611
2020's3 (4.05)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.62 (24.57)
Research Supply Index4.36 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index43.69 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.30%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other76 (98.70%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]